本文選題：手術(shù)室內(nèi)干預(yù) + 糖尿病�。� 參考：《中華醫(yī)院感染學(xué)雜志》2017年09期

【摘要】：目的探討手術(shù)室內(nèi)干預(yù)措施對并發(fā)糖尿病患者手術(shù)部位感染的預(yù)防控制效果,為提升患者的生存質(zhì)量提供科學(xué)依據(jù)。方法選取2012年1月-2015年12月醫(yī)院行手術(shù)治療并發(fā)糖尿病的患者102例,分為干預(yù)組與對照組,各51例;對照組患者采用合并糖尿病手術(shù)術(shù)后干預(yù)方案進行干預(yù),干預(yù)組采用在常規(guī)干預(yù)的基礎(chǔ)上實施手術(shù)室內(nèi)干預(yù)措施;對比兩組患者手術(shù)部位感染率、感染并發(fā)癥發(fā)生率、病原菌分布及耐藥性。結(jié)果干預(yù)組患者的手術(shù)部位感染率(2.0%)顯著低于對照組(25.5%),兩組比較差異有統(tǒng)計學(xué)意義(P0.05);與患者感染并發(fā)癥發(fā)生率相比,干預(yù)組患者的感染并發(fā)癥發(fā)生率(7.8%)顯著低于對照組(25.5%),兩組比較差異有統(tǒng)計學(xué)意義(P0.05);14例感染患者中分離出病原菌17株,其中革蘭陰性菌占76.5%,主要以大腸埃希菌、陰溝腸桿菌、銅綠假單胞菌為主,分別占35.3%、17.6%、11.8%;革蘭陽性菌占17.6%,真菌占5.9%;大腸埃希菌產(chǎn)超廣譜β-內(nèi)酰胺酶株占66.7%,耐藥性分析結(jié)果顯示,對亞胺培南、呋喃妥因、美羅培南耐藥率為0,對環(huán)丙沙星、氨芐西林、氨曲南耐藥性較高,分別占83.3%、100.0%、83.3%。結(jié)論并發(fā)糖尿病患者手術(shù)部位感染以革蘭陰性菌為主,手術(shù)室內(nèi)干預(yù)措施可顯著降低患者的手術(shù)部位感染率。
[Abstract]:Objective to explore the effect of intraoperative intervention on the prevention and control of surgical site infection in patients with diabetes mellitus, and to provide scientific basis for improving the quality of life of patients. Methods from January 2012 to December 2015, 102 patients with diabetes were divided into two groups: the intervention group (n = 51) and the control group (n = 51). The intervention group was treated with intraoperative intervention on the basis of routine intervention, and the infection site infection rate, infection complication rate, pathogenic bacteria distribution and drug resistance were compared between the two groups. Results the operative site infection rate in the intervention group was significantly lower than that in the control group (P 0.05), and the incidence of infection complications was significantly higher in the intervention group than in the control group (P 0.05). The incidence of infection complications in the intervention group was significantly lower than that in the control group. There was a statistically significant difference between the two groups. 17 strains of pathogenic bacteria were isolated from 14 cases of infection, of which 76.5 were Gram-negative bacteria, mainly Escherichia coli and Enterobacter cloacae. Pseudomonas aeruginosa was predominant, accounting for 35.3B (17.6C) 11.8; Gram-positive bacteria 17.6am; fungi 5.9m; Escherichia coli producing extended-spectrum 尾 -lactamases (66.7%). Drug resistance analysis showed that resistance rates to imipenem, furantoin, meropenem were 0, and ciprofloxacin to ciprofloxacin, to imipenem, furantoin, meropenem, and to ciprofloxacin, to imipenem, furantoin, meropenem, and to ciprofloxacin. Ampicillin and aztreonam were more resistant to ampicillin and ampicillin, accounting for 83.3% and 83.3%, respectively. Conclusion Gram-negative bacteria are the main infection of surgical site in patients with diabetes mellitus. Intervention in the operating room can significantly reduce the infection rate of surgical sites in patients with diabetes mellitus.
【作者單位】： 內(nèi)蒙古科技大學(xué)包頭醫(yī)學(xué)院第一附屬醫(yī)院手術(shù)室;內(nèi)蒙古科技大學(xué)包頭醫(yī)學(xué)院第一附屬醫(yī)院兒科;內(nèi)蒙古科技大學(xué)包頭醫(yī)學(xué)院第一附屬醫(yī)院麻醉科;內(nèi)蒙古科技大學(xué)包頭醫(yī)學(xué)院第一附屬醫(yī)院神經(jīng)外科;內(nèi)蒙古科技大學(xué)包頭醫(yī)學(xué)院第一附屬醫(yī)院體檢科;
【分類號】：R587.1;R619.3
，

本文編號：1851045